These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26306937)

  • 61. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
    Amiott EA; Lott P; Soto J; Kang PB; McCaffery JM; DiMauro S; Abel ED; Flanigan KM; Lawson VH; Shaw JM
    Exp Neurol; 2008 May; 211(1):115-27. PubMed ID: 18316077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Massively Parallel Sequencing Detected a Mutation in the MFN2 Gene Missed by Sanger Sequencing Due to a Primer Mismatch on an SNP Site.
    Neupauerová J; Grečmalová D; Seeman P; Laššuthová P
    Ann Hum Genet; 2016 May; 80(3):182-6. PubMed ID: 26916081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations.
    Nan H; Hata T; Fukao T; Fukao T; Chen W; Kurita T; Natori T; Takiyama Y
    Intern Med; 2021 Dec; 60(24):3969-3974. PubMed ID: 34121014
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.
    Tucci A; Liu YT; Preza E; Pitceathly RD; Chalasani A; Plagnol V; Land JM; Trabzuni D; Ryten M; ; Jaunmuktane Z; Reilly MM; Brandner S; Hargreaves I; Hardy J; Singleton AB; Abramov AY; Houlden H
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):486-92. PubMed ID: 24198383
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Charcot-Marie Tooth Disease Mutation R94Q in MFN2 Decreases ATP Production but Increases Mitochondrial Respiration under Conditions of Mild Oxidative Stress.
    Wolf C; Zimmermann R; Thaher O; Bueno D; Wüllner V; Schäfer MKE; Albrecht P; Methner A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31640251
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction.
    Del Bo R; Moggio M; Rango M; Bonato S; D'Angelo MG; Ghezzi S; Airoldi G; Bassi MT; Guglieri M; Napoli L; Lamperti C; Corti S; Federico A; Bresolin N; Comi GP
    Neurology; 2008 Dec; 71(24):1959-66. PubMed ID: 18946002
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
    Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
    Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.
    Auranen M; Ylikallio E; Toppila J; Somer M; Kiuru-Enari S; Tyynismaa H
    Neurogenetics; 2013 May; 14(2):123-32. PubMed ID: 23456260
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2.
    Verhoeven K; Claeys KG; Züchner S; Schröder JM; Weis J; Ceuterick C; Jordanova A; Nelis E; De Vriendt E; Van Hul M; Seeman P; Mazanec R; Saifi GM; Szigeti K; Mancias P; Butler IJ; Kochanski A; Ryniewicz B; De Bleecker J; Van den Bergh P; Verellen C; Van Coster R; Goemans N; Auer-Grumbach M; Robberecht W; Milic Rasic V; Nevo Y; Tournev I; Guergueltcheva V; Roelens F; Vieregge P; Vinci P; Moreno MT; Christen HJ; Shy ME; Lupski JR; Vance JM; De Jonghe P; Timmerman V
    Brain; 2006 Aug; 129(Pt 8):2093-102. PubMed ID: 16714318
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Sporadic Case of Charcot-Marie-Tooth Disease Type 2 with Left Vocal Fold Palsy due to Mitofusin 2 Mutation.
    Kanemaru K; Ogawa G; Mochizuki H; Nakazato M; Shiomi K
    Intern Med; 2019 Jul; 58(14):2091-2093. PubMed ID: 30996168
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics.
    Larrea D; Pera M; Gonnelli A; Quintana-Cabrera R; Akman HO; Guardia-Laguarta C; Velasco KR; Area-Gomez E; Dal Bello F; De Stefani D; Horvath R; Shy ME; Schon EA; Giacomello M
    Hum Mol Genet; 2019 Jun; 28(11):1782-1800. PubMed ID: 30649465
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical, electrophysiological and pathological findings of a patient with CMT2 due to the p.Ala738Val mitofusin 2 mutation.
    Luigetti M; Fabrizi GM; Taioli F; Conte A; Del Grande A; Sabatelli M
    J Neurol Sci; 2011 Aug; 307(1-2):168-70. PubMed ID: 21601224
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MFN2-related genetic and clinical features in a cohort of Chinese CMT2 patients.
    Xie Y; Li X; Liu L; Hu Z; Huang S; Zhan Y; Zi X; Xia K; Tang B; Zhang R
    J Peripher Nerv Syst; 2016 Mar; 21(1):38-44. PubMed ID: 26801520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An integrative analysis of genotype-phenotype correlation in Charcot Marie Tooth type 2A disease with MFN2 variants: A case and systematic review.
    Zhang Y; Pang D; Wang Z; Ma L; Chen Y; Yang L; Xiao W; Yuan H; Chang F; Ouyang H
    Gene; 2023 Oct; 883():147684. PubMed ID: 37536398
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel mutation of the mitofusin 2 gene in a family with Charcot-Marie-Tooth disease type 2.
    Bergamin G; Dalla Torre C; Cacciavillani M; Lucchetta M; Boaretto F; Campagnolo M; Mostacciuolo ML; Briani C
    Muscle Nerve; 2014 Jan; 49(1):145-6. PubMed ID: 23929728
    [No Abstract]   [Full Text] [Related]  

  • 76. Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations.
    Brockmann K; Dreha-Kulaczewski S; Dechent P; Bönnemann C; Helms G; Kyllerman M; Brück W; Frahm J; Huehne K; Gärtner J; Rautenstrauss B
    J Neurol; 2008 Jul; 255(7):1049-58. PubMed ID: 18425620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early-onset Charcot-Marie-Tooth patients with mitofusin 2 mutations and brain involvement.
    Chung KW; Suh BC; Cho SY; Choi SK; Kang SH; Yoo JH; Hwang JY; Choi BO
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1203-6. PubMed ID: 20587496
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MFN2 transcripts escaping from nonsense-mediated mRNA decay pathway cause Charcot-Marie-Tooth disease type 2A2.
    Kawarai T; Yamasaki K; Mori A; Takamatsu N; Osaki Y; Banzrai C; Miyamoto R; Oki R; Pedace L; Orlacchio A; Nodera H; Hashiguchi A; Higuchi Y; Takashima H; Nishida Y; Izumi Y; Kaji R
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1263-1265. PubMed ID: 27154191
    [No Abstract]   [Full Text] [Related]  

  • 79. Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
    Stavropoulos F; Georgiou E; Schiza N; Bell S; Baloh RH; Kleopa KA; Sargiannidou I
    J Peripher Nerv Syst; 2023 Sep; 28(3):329-340. PubMed ID: 37220142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy.
    Sawyer SL; Cheuk-Him Ng A; Innes AM; Wagner JD; Dyment DA; Tetreault M; ; Majewski J; Boycott KM; Screaton RA; Nicholson G
    Hum Mol Genet; 2015 Sep; 24(18):5109-14. PubMed ID: 26085578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.